Can a common drug turn back the clock on aging?
NCT ID NCT05835999
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tests whether a low dose of everolimus, a drug that targets a key aging pathway, can safely improve how the body ages in people aged 55-80 with insulin resistance or prediabetes. Participants take the drug daily or weekly for 24 weeks, and researchers measure changes in metabolism, heart function, and brain health. The goal is to see if this approach can reduce age-related decline, not cure aging itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Wisconsin-Madison
Madison, Wisconsin, 53705, United States
Conditions
Explore the condition pages connected to this study.